Stockreport

Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026 [Yahoo! Finance]

Nyxoah SA - Ordinary Shares  (NYXH) 
PDF 70 VAC approvals with active implants at 50+ accounts, and reported $4.5 million of U.S. revenue in Q4 with management forecasting strong double-digit growth. The Geni [Read more]